Tiopronin safety in cystinuria: first real-world pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS): an EAU YAU and Endourology sections review.
Saved in:
| Title: | Tiopronin safety in cystinuria: first real-world pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS): an EAU YAU and Endourology sections review. |
|---|---|
| Authors: | Ergül, Rifat Burak1,2,3,4 (AUTHOR) rifat.ergul@istanbul.edu.tr, Gürlek, Ismail Taha5 (AUTHOR), Özervarlı, M. Fırat1 (AUTHOR), Özcan, Şeyda Gül6 (AUTHOR), Pietropaolo, Amelia2,7 (AUTHOR), Tsaturyan, Arman2,8 (AUTHOR), Juliebø-Jones, Patrick2,9 (AUTHOR), Tzelves, Lazaros2,10 (AUTHOR), Şener, Tarik Emre2,11 (AUTHOR), Dönmez, M. İrfan12 (AUTHOR), Oktar, Tayfun12 (AUTHOR), Somani, Bhaskar7 (AUTHOR), Tefik, Tzevat1 (AUTHOR) tzevat.tefik@gmail.com |
| Source: | Pediatric Nephrology. Apr2026, Vol. 41 Issue 4, p1087-1095. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 0931041X |
|---|---|
| DOI: | 10.1007/s00467-025-07043-2 |
